Chengwei Capital is a venture capital firm that seeks to make long-term investment in and support numerous industry leaders in many areas. The firm was founded in 1999 and is based in Shanghai, China.
Chengwei Capital focuses their investments on the communication software, enterprise software, financial services, IC design, niche component manufacturing, healthcare and media sectors. They prefer to invest in China.
Investment
Chengwei Capital's investments include SiFive, Sensely, Xiaoduo, Sila Nanotechnologies, AInnovation, Ruigu, Baibu, Liaotianbao and Tot Biopharm.
Their exited investments include Youku, Hello TransTech, Tot Biopharm, Yesmywine and Sohu.com.
Timeline
Associated investment funds
People
Name
Role
LinkedIn
Charles Edwards
Employee
Yihong Ge
Employee
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Mars W. Mosqueda Jr.
March 14, 2021
DealStreetAsia
Chengwei's recent investments include Lyvgen Biopharma and agritech firm XAG.
References
Is a
Company attributes
Industry
Location
Crunchbase
Pitchbook
Full address
Building A, 201 Anfu Road, Xuhui District, Shanghai
Founded date
1999
Venture Capital Firm attributes
Invested in
